According to this study, Global Breakthrough Therapy Drugs market size will reach US$ million by 2031.

Global Breakthrough Therapy Drugs Market Size and Outlook 2025-31

According to this study, the global Breakthrough Therapy Drugs market size will reach US$ million by 2031. Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two factors determine the efficiency of breakthrough therapy drug, they are the magnitude of the treatment effect and observed clinical difference over the existed drug. The standard for breakthrough therapy drug is not same as standard drug approval because, in breakthrough therapy, morbidity and mortality considered for approval of the drug. They are meant to be administered by itself or in combinations. Breakthrough therapy drug development is cost effective due to faster approval of drugs on limited data from the FDA. Manufacturer of breakthrough therapy drugs has to develop additional post-marketing surveillance data for the other reimbursements and market access. Presently available breakthrough therapy medicinal products in the market belong to the treatment class of oncology, infectious diseases, cardiovascular conditions, etc. The designation is given when the drug is in 1stor 2ndstage of clinical trials. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Breakthrough Therapy Drugs Industry Forecast looks at past sales and reviews total world Breakthrough Therapy Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Breakthrough Therapy Drugs sales for 2025 through 2031. With Breakthrough Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breakthrough Therapy Drugs industry. This Insight Report provides a comprehensive analysis of the global Breakthrough Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Breakthrough Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Breakthrough Therapy Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breakthrough Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breakthrough Therapy Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Breakthrough Therapy Drugs market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Oncology &nbsp;&nbsp;&nbsp; Anti-Viral &nbsp;&nbsp;&nbsp; Neurology &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Ambulatory Services This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company &nbsp;&nbsp;&nbsp; Genentech &nbsp;&nbsp;&nbsp; Gilead &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Vertex Pharmaceuticals Incorporated

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Breakthrough Therapy Drugs Market Size (2020-2031) &nbsp;2.1.2 Breakthrough Therapy Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Breakthrough Therapy Drugs by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Breakthrough Therapy Drugs Segment by Type &nbsp;2.2.1 Oncology &nbsp;2.2.2 Anti-Viral &nbsp;2.2.3 Neurology &nbsp;2.2.4 Others &nbsp;2.3 Breakthrough Therapy Drugs Market Size by Type &nbsp;2.3.1 Breakthrough Therapy Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Breakthrough Therapy Drugs Market Size Market Share by Type (2020-2025) &nbsp;2.4 Breakthrough Therapy Drugs Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Ambulatory Services &nbsp;2.5 Breakthrough Therapy Drugs Market Size by Application &nbsp;2.5.1 Breakthrough Therapy Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Breakthrough Therapy Drugs Market Size Market Share by Application (2020-2025) 3 Breakthrough Therapy Drugs Market Size by Player &nbsp;3.1 Breakthrough Therapy Drugs Market Size Market Share by Player &nbsp;3.1.1 Global Breakthrough Therapy Drugs Revenue by Player (2020-2025) &nbsp;3.1.2 Global Breakthrough Therapy Drugs Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Breakthrough Therapy Drugs Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Breakthrough Therapy Drugs by Region &nbsp;4.1 Breakthrough Therapy Drugs Market Size by Region (2020-2025) &nbsp;4.2 Global Breakthrough Therapy Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Breakthrough Therapy Drugs Market Size Growth (2020-2025) &nbsp;4.4 APAC Breakthrough Therapy Drugs Market Size Growth (2020-2025) &nbsp;4.5 Europe Breakthrough Therapy Drugs Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Breakthrough Therapy Drugs Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Breakthrough Therapy Drugs Market Size by Country (2020-2025) &nbsp;5.2 Americas Breakthrough Therapy Drugs Market Size by Type (2020-2025) &nbsp;5.3 Americas Breakthrough Therapy Drugs Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Breakthrough Therapy Drugs Market Size by Region (2020-2025) &nbsp;6.2 APAC Breakthrough Therapy Drugs Market Size by Type (2020-2025) &nbsp;6.3 APAC Breakthrough Therapy Drugs Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Breakthrough Therapy Drugs Market Size by Country (2020-2025) &nbsp;7.2 Europe Breakthrough Therapy Drugs Market Size by Type (2020-2025) &nbsp;7.3 Europe Breakthrough Therapy Drugs Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Breakthrough Therapy Drugs by Region (2020-2025) &nbsp;8.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Breakthrough Therapy Drugs Market Forecast &nbsp;10.1 Global Breakthrough Therapy Drugs Forecast by Region (2026-2031) &nbsp;10.1.1 Global Breakthrough Therapy Drugs Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Breakthrough Therapy Drugs Forecast &nbsp;10.1.3 APAC Breakthrough Therapy Drugs Forecast &nbsp;10.1.4 Europe Breakthrough Therapy Drugs Forecast &nbsp;10.1.5 Middle East & Africa Breakthrough Therapy Drugs Forecast &nbsp;10.2 Americas Breakthrough Therapy Drugs Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Breakthrough Therapy Drugs Forecast &nbsp;10.2.2 Canada Market Breakthrough Therapy Drugs Forecast &nbsp;10.2.3 Mexico Market Breakthrough Therapy Drugs Forecast &nbsp;10.2.4 Brazil Market Breakthrough Therapy Drugs Forecast &nbsp;10.3 APAC Breakthrough Therapy Drugs Forecast by Region (2026-2031) &nbsp;10.3.1 China Breakthrough Therapy Drugs Market Forecast &nbsp;10.3.2 Japan Market Breakthrough Therapy Drugs Forecast &nbsp;10.3.3 Korea Market Breakthrough Therapy Drugs Forecast &nbsp;10.3.4 Southeast Asia Market Breakthrough Therapy Drugs Forecast &nbsp;10.3.5 India Market Breakthrough Therapy Drugs Forecast &nbsp;10.3.6 Australia Market Breakthrough Therapy Drugs Forecast &nbsp;10.4 Europe Breakthrough Therapy Drugs Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Breakthrough Therapy Drugs Forecast &nbsp;10.4.2 France Market Breakthrough Therapy Drugs Forecast &nbsp;10.4.3 UK Market Breakthrough Therapy Drugs Forecast &nbsp;10.4.4 Italy Market Breakthrough Therapy Drugs Forecast &nbsp;10.4.5 Russia Market Breakthrough Therapy Drugs Forecast &nbsp;10.5 Middle East & Africa Breakthrough Therapy Drugs Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Breakthrough Therapy Drugs Forecast &nbsp;10.5.2 South Africa Market Breakthrough Therapy Drugs Forecast &nbsp;10.5.3 Israel Market Breakthrough Therapy Drugs Forecast &nbsp;10.5.4 Turkey Market Breakthrough Therapy Drugs Forecast &nbsp;10.6 Global Breakthrough Therapy Drugs Forecast by Type (2026-2031) &nbsp;10.7 Global Breakthrough Therapy Drugs Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Breakthrough Therapy Drugs Forecast 11 Key Players Analysis &nbsp;11.1 Merck &nbsp;11.1.1 Merck Company Information &nbsp;11.1.2 Merck Breakthrough Therapy Drugs Product Offered &nbsp;11.1.3 Merck Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Merck Main Business Overview &nbsp;11.1.5 Merck Latest Developments &nbsp;11.2 Pfizer &nbsp;11.2.1 Pfizer Company Information &nbsp;11.2.2 Pfizer Breakthrough Therapy Drugs Product Offered &nbsp;11.2.3 Pfizer Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Pfizer Main Business Overview &nbsp;11.2.5 Pfizer Latest Developments &nbsp;11.3 AbbVie &nbsp;11.3.1 AbbVie Company Information &nbsp;11.3.2 AbbVie Breakthrough Therapy Drugs Product Offered &nbsp;11.3.3 AbbVie Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 AbbVie Main Business Overview &nbsp;11.3.5 AbbVie Latest Developments &nbsp;11.4 Bristol-Myers Squibb Company &nbsp;11.4.1 Bristol-Myers Squibb Company Company Information &nbsp;11.4.2 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product Offered &nbsp;11.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Bristol-Myers Squibb Company Main Business Overview &nbsp;11.4.5 Bristol-Myers Squibb Company Latest Developments &nbsp;11.5 Genentech &nbsp;11.5.1 Genentech Company Information &nbsp;11.5.2 Genentech Breakthrough Therapy Drugs Product Offered &nbsp;11.5.3 Genentech Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Genentech Main Business Overview &nbsp;11.5.5 Genentech Latest Developments &nbsp;11.6 Gilead &nbsp;11.6.1 Gilead Company Information &nbsp;11.6.2 Gilead Breakthrough Therapy Drugs Product Offered &nbsp;11.6.3 Gilead Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Gilead Main Business Overview &nbsp;11.6.5 Gilead Latest Developments &nbsp;11.7 Novartis &nbsp;11.7.1 Novartis Company Information &nbsp;11.7.2 Novartis Breakthrough Therapy Drugs Product Offered &nbsp;11.7.3 Novartis Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Novartis Main Business Overview &nbsp;11.7.5 Novartis Latest Developments &nbsp;11.8 Vertex Pharmaceuticals Incorporated &nbsp;11.8.1 Vertex Pharmaceuticals Incorporated Company Information &nbsp;11.8.2 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product Offered &nbsp;11.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Vertex Pharmaceuticals Incorporated Main Business Overview &nbsp;11.8.5 Vertex Pharmaceuticals Incorporated Latest Developments 12 Research Findings and Conclusion

Report	Global Breakthrough Therapy Drugs Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI24041

Buyer Information

Order Summary